US 7655752
TNF-α converting enzyme inhibitory agents and method of using same
granted A61KA61K38/00
Quick answer
US patent 7655752 (TNF-α converting enzyme inhibitory agents and method of using same) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K38/00